ASX200 Index Review - A Handful of Changes
S&P Dow Jones Indices announced changes to the S&P/ASX 200 (AS51 INDEX) today. The changes are effective at the open of trading on 22 June...
457 Views
Mesoblast - An important next several months
It is going to be a busy next several months for Mesoblast. The company recently completed filing the biologics license application (BLA) for...
525 Views
Mesoblast - Moving closer to key catalysts
Mesoblast is approaching some very key catalysts. The company expects to complete its filing of Remestemcel-L in pediatric acute graft versus host...
1.1k Views
Mesoblast - Increasingly positive on aGvHD
With a positive primary endpoint plus 180-day data in acute graft versus host disease (aGvHD), Mesoblast is on track for its first US approval....
1k Views
Australia Short Interest - August in Review
Of the 134 companies that reported annual results in August, 65% missed their targets on the top line and just over half reported a rise in profits...
450 Views